Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Tuesday's After-Market Session

Author: Benzinga Insights | April 08, 2025 05:05pm

Gainers

  • Venus Concept (NASDAQ:VERO) shares rose 129.5% to $6.61 during Tuesday's after-market session. The market value of their outstanding shares is at $4.3 million.
  • SCWorx (NASDAQ:WORX) shares moved upwards by 60.8% to $1.28. The market value of their outstanding shares is at $2.6 million.
  • Salarius Pharmaceuticals (NASDAQ:SLRX) shares increased by 34.26% to $1.09. The company's market cap stands at $1.8 million.
  • NAYA Biosciences (NASDAQ:NAYA) shares moved upwards by 13.98% to $2.2. The market value of their outstanding shares is at $10.8 million.
  • Aethlon Medical (NASDAQ:AEMD) stock moved upwards by 12.12% to $0.37. The company's market cap stands at $7.6 million.
  • Anixa Biosciences (NASDAQ:ANIX) shares moved upwards by 10.88% to $2.63. The market value of their outstanding shares is at $84.6 million.

Losers

  • Vincerx Pharma (NASDAQ:VINC) stock declined by 55.6% to $0.24 during Tuesday's after-market session.
  • NanoVibronix (NASDAQ:NAOV) shares declined by 14.31% to $6.11. The market value of their outstanding shares is at $4.6 million.
  • Protagenic Therapeutics (NASDAQ:PTIX) shares fell 12.69% to $0.24. The company's market cap stands at $1.8 million.
  • 180 Life Sciences (NASDAQ:ATNF) stock declined by 12.26% to $0.62. The market value of their outstanding shares is at $2.4 million.
  • Revelation Biosciences (NASDAQ:REVB) stock declined by 11.39% to $3.27. The company's market cap stands at $2.9 million.
  • ABVC BioPharma (NASDAQ:ABVC) stock decreased by 8.36% to $0.82. The company's market cap stands at $19.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ABVC AEMD ANIX ATNF NAOV NAYA PTIX REVB SLRX VERO VINC WORX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist